IntegraGen believes that through its technologies it can reveal the underlying genetic component of Type 2 Diabetes, thus offering not only help in the understanding of this important disease, but also to provide a quantitative measure for predicting the proclivity for Late Onset Diabetes.
IntegraGen to participate to the Child Neurology Society 37th Annual Meeting - November 5-8, 2008 in Santa-Clara Convention Center. Visit us booth 26!
IntegraGen to speak at American Academy of Pediatrics's (AAP) 2008 National Conference in Boston, MA - October 11-14, 2008 - visit us at booth 3772.
> more
